Overview
Clarium is a New York City company founded in 2020[2] that develops artificial intelligence software for the healthcare sector[1]. The company's platform enables hospitals to automate supply chain tasks, increase collaboration, and streamline operations[1].
Funding & milestones
1 events found for Clarium
- Undated
Series AVenture / equityDetails$27M
Reported amount $27,000,000
Source not attached to this recordDeal record
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Leadership & org chart
Backers
General Catalyst
Global venture capital and investment firm with a New York office
AlleyCorp
New York venture firm founded by Kevin Ryan that founds and invests in transformative companies in New York and worldwide, incubating startups and backing early-stage companies such as MongoDB, Business Insider and Gilt Groupe.
AlleyCorp
AlleyCorp is a venture capital firm and startup incubator that founds and invests in early-stage technology companies across various sectors.
Northzone
Northzone is a multi-stage venture capital fund that invests across seed to growth stages. The page lists portfolio companies and investment themes including AI, materials science, and enterprise software.
1984 Ventures
1984 Ventures is a venture capital firm that invests in founders using AI to solve real-world problems across vertical AI, developer tools and infrastructure, and digital health sectors. The site displays portfolio companies, investment thesis areas, and resources for founders seeking funding.
Kaiser Permanente Ventures
Kaiser Permanente Ventures makes investments in promising healthcare companies targeting areas of real need. The organization focuses on solutions that provide value for patients, providers, and healthcare delivery systems.
TMC Venture Fund
TMC Venture Fund is a $75M evergreen venture fund that invests in companies in digital health, medical devices, and therapeutics, with 31 portfolio companies and 3 successful exits since its launch in 2017.
Something wrong or missing? Send an update. Fixed within 24 hours.